Proactive news snapshot: CentralNic, Savannah Resources, Landore Resources, Ariana Resources …
CentralNic Group PLC (LON:CNIC), the global internet platform that derives revenue from the subscription sales of domain names and web services, has announced the appointment of Iain McDonald as its non-executive chairman with immediate effect. In a statement, the group noted that McDonald will replace Mike Turner, who, while stepping down as chairman, will remain a non-executive director of the company.
Savannah Resources PLC (LON:SAV) has been granted a mining licence for its Mutamba mineral sands project in Mozambique, which the firm operates under a joint venture with mining major Rio Tinto plc (LON:RIO). The licence covers 11,948 hectares and is valid to April 2044, with the possibility of an additional 25-year extension. The licence is the first of three contiguous concessions to be issued that will result in the full tenement permitting of Mutamba.
Landore Resources Ltd (LON:LND) has revealed the results of its 2019 soil sampling program carried out along strike to the east and west of its BAM gold project on the Junior Lake property in Ontario, Canada. The program has provided drill targets from the western extent of the BAM gold resource all the way to Juno Lake, a distance of approximately 1,300 metres. It has also provided targets to the east.
Ariana Resources PLCs (LON:AAU) proposed new partner in Turkey has commissioned an independent review of the Kiziltepe, Tavsan and Salinbas projects in Turkey as part of its farm-in due diligence. The unnamed group has offered to buy of 17% of Salinbas directly from Ariana for US$5mln and will inject a further US$8mln to get the project up and running.
Two of AIM's pharmaceutical services providers – Open Orphan PLC (LON:ORPH) and hVIVO PLC (LON:HVO) – are planning to merge. The boards of the two companies have agreed on a merger whereby hVIVO shareholders will receive 2.47 Open Orphan shares for every hVIVO share they hold. Based on Friday's closing price for Open Orphan shares, the terms value each hVIVO share at 15.56p and hVIVO in its entirety at around £12.96mln.
OptiBiotix Health PLC (LON:OPTI) said its fully-owned subsidiary ProBiotix Health Ltd. has signed an exclusive agreement with CTC Far East Philippines, a subsidiary of the CTC Group, for the distribution of its proprietary formulation CholBiome®x3, in the Philippines. In a statement, the life sciences business developing compounds to tackle obesity, cardiovascular disease and diabetes, said the agreement will see ProBiotix supply CholBiome®x3, featuring its cholesterol and blood pressure-reducing probiotic strain Lactobacillus plantarum LPLDL®, to CTC for distribution in the Asian country.
C4X Discovery Holdings (LON:C4XD) said a clinical trial of its molecule to treat opioid addiction is “in sight”, following the selection of Altasciences to conduct a phase I study. In March last year, C4X signed a licensing agreement with Indivior PLC (LON:INDV) to develop and commercialise its oral Orexin-1 receptor antagonist (C4X_3256/INDV-2000), which aims to treat opioid addiction by targeting the "craving" process, meaning it may be applied across a broad range of substance use disorders. On Monday, Altasciences revealed that it has been selected by Indivior to conduct a phase I study to assess INDV-2000s safety, tolerability, and how the drug behaves in the bodies of healthy volunteers, both fasting and fed.
IronRidge Resources Ltd (LON:IRR) has commenced drilling at its Zaranou gold project in Côte d'Ivoire. The aim is to test approximately eight kilometres of strike, consisting of hard-rock artisanal mining, anomalous geochemistry and coincident magnetic anomalies. The company will undertake approximately 6,500 metres of air core drilling and approximately 1,500 metres of deeper reverse circulation drilling.
Directa Plus PLC (LON:DCTA) said its newly acquired subsidiary Setcar has been awarded a US$1mln contract to provide environmental decontamination services at a gas field offshore Romania. The three-month contract covers the period of the appraisal of the Trident gas field, contained in Block 30 of the Trinity-1X gas project, which is operated by Lukoil and Romgaz. The field's contractor, GSP will use Directas Grafysorber, a graphene-based oil pollution treatment which is sustainably produced, non-flammable and reusable and allows the recovery of absorbed hydrocarbons.
Angling Direct PLC (LON:ANG) has announced the opening of its latest retail store and revealed details of what it described as a record-breaking trading performance for Black Friday. The leisure retailer said that sales for the week of Black Friday amounted to £1.86mln, up 11.3% on last year, and, that in this busy pre-Christmas sales period it served some 5,868 customers.
ADES International Holding PLC (LON:ADES) has landed its first onshore deep drilling contracts in Kuwait, under its lump-sum turnkey arrangement with Baker Hughes. Two contracts were awarded by Baker Hughes. Each come with an initial two-year term. Both are expected to commence in the second quarter of 2020, and, the day rates are said to be similar to ADES existing fleet in Kuwait.
Shefa Gems Ltd (LON:SEFA) said that a competent person acting for the group has established that the gemstone resource at its Kishon Mid-Reach Zone 1 and Zone 2 projects in Israel should generate revenue of US$41 for every tonne of rock mined. Shefa Gems is now at an advanced stage of planning and development in its trial mining phase.
Regional offices owner Circle Property PLC (LON:CRC) said it is well-positioned to deliver full-year expectations of strong growth in net asset value (NAV). In its interim results statement covering the six months to the end of September, Circle said the estimated NAV per share on 30 September stood at 278p, up from 275p a year earlier and 277p at the end of March.
Integumen PLC (LON:SKIN) has said it will raise approximately £1.368mln from a share subscription and placing to provide working capital to help it deliver the £4mln in revenues guided for 2020. In a statement, the AIM-listed company said its broker, Turner Pope will issue, in aggregate, 91,253,530 new ordinary shares at 1.5p each, utilising all of the funding headroom currently available to the group without the need for further shareholder approval.